NCT05208944AteganosineNSCLCcemiplimabTHIOChemotherapyDocetaxel
… and activation of antitumor immunogenicity.Methods The study ( NCT05208944) includes adults with advanced NSCLC, who had relapsed after 2 …
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05208944 ×
NCT05208944
This funder is selected. Its supporting articles are shown below.